Mutations in CCT5 have been associated with various adverse health outcomes, including distal and early onset motor neuropathy, chaperonopathy, hereditary sensory neuropathies, and various cancers, such as rectal cancer and non-small cell lung cancer (NSCLC)10–14. Here, CCT5 is linked to non-small cell lung carcinoma.